<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">Korean J Anesthesiol</journal-id><journal-id journal-id-type="publisher-id">KJAE</journal-id><journal-title-group><journal-title>Korean Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="ppub">2005-6419</issn><issn pub-type="epub">2005-7563</issn><publisher><publisher-name>The Korean Society of Anesthesiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25097732</article-id><article-id pub-id-type="pmc">4121500</article-id><article-id pub-id-type="doi">10.4097/kjae.2014.67.1.8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research Article</subject></subj-group></article-categories><title-group><article-title>The effects of different loading doses of dexmedetomidine on sedation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sim</surname><given-names>Jae Hwan</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Hyun Jeong</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Sang Tae</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib></contrib-group><aff id="A1">Department of Anesthesiology and Pain Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.</aff><author-notes><corresp>Corresponding author: Sang Tae Kim, M.D., Department of Anesthesiology and Pain Medicine, Chungbuk National University College of Medicine, 776, 1sunhwan-ro, Heungdeok-gu, Cheongju 361-711, Korea. Tel: 82-43-269-6237, Fax: 82-43-272-0264, <email>kimst@chungbuk.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>29</day><month>7</month><year>2014</year></pub-date><volume>67</volume><issue>1</issue><fpage>8</fpage><lpage>12</lpage><history><date date-type="received"><day>04</day><month>11</month><year>2013</year></date><date date-type="rev-recd"><day>19</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>Copyright © the Korean Society of Anesthesiologists, 2014</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3244" xml_f="3254" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3265" xml_f="3449" txt_i="22" txt_f="206">Dexmedetomidine is a useful sedative drug with various uses. We designed this study to investigate the clinical effects and complications of different loading doses, 0.5 and 1.0 µg/kg.</offsets></p></sec><sec><title><offsets xml_i="3471" xml_f="3478" txt_i="208" txt_f="215">Methods</offsets></title><p><offsets xml_i="3489" xml_f="3882" txt_i="216" txt_f="609">Forty six patients, of American Society of Anesthesiologists physical status I and II, who required elective and emergency operation under spinal anesthesia were randomly assigned to group L or group H. Group L received a loading dose of 0.5 µg/kg for 10 minutes while group H received 1.0 µg/kg. Bispectral index (BIS), systolic blood pressure, heart rate, and Ramsay score were recorded at T</offsets><sub><offsets xml_i="3887" xml_f="3888" txt_i="609" txt_f="610">0</offsets></sub><offsets xml_i="3894" xml_f="3914" txt_i="610" txt_f="630"> (before loading), T</offsets><sub><offsets xml_i="3919" xml_f="3920" txt_i="630" txt_f="631">L</offsets></sub><offsets xml_i="3926" xml_f="3953" txt_i="631" txt_f="658"> (just after loading) and T</offsets><sub><offsets xml_i="3958" xml_f="3968" txt_i="658" txt_f="668">10, 20, 30</offsets></sub><offsets xml_i="3974" xml_f="4002" txt_i="668" txt_f="696"> (10, 20, 30 minutes after T</offsets><sub><offsets xml_i="4007" xml_f="4008" txt_i="696" txt_f="697">L</offsets></sub><offsets xml_i="4014" xml_f="4147" txt_i="697" txt_f="830">). Complications, drug use, lowest BIS and time to reach BIS 80 after termination of dexmedetomidine were recorded during this study.</offsets></p></sec><sec><title><offsets xml_i="4169" xml_f="4176" txt_i="832" txt_f="839">Results</offsets></title><p><offsets xml_i="4187" xml_f="4240" txt_i="840" txt_f="893">In group H, BIS value decreased significantly after T</offsets><sub><offsets xml_i="4245" xml_f="4246" txt_i="893" txt_f="894">L</offsets></sub><offsets xml_i="4252" xml_f="4280" txt_i="894" txt_f="922"> compared to the baseline (T</offsets><sub><offsets xml_i="4285" xml_f="4286" txt_i="922" txt_f="923">0</offsets></sub><offsets xml_i="4292" xml_f="4319" txt_i="923" txt_f="950">), while in group L after T</offsets><sub><offsets xml_i="4324" xml_f="4326" txt_i="950" txt_f="952">10</offsets></sub><offsets xml_i="4332" xml_f="4407" txt_i="952" txt_f="1027">. Between two groups, BIS values showed a significant differences only at T</offsets><sub><offsets xml_i="4412" xml_f="4414" txt_i="1027" txt_f="1029">10</offsets></sub><offsets xml_i="4420" xml_f="4527" txt_i="1029" txt_f="1136">, BIS of group H was lower than that of group L. Ramsay score showed no significant differences except in T</offsets><sub><offsets xml_i="4532" xml_f="4533" txt_i="1136" txt_f="1137">L</offsets></sub><offsets xml_i="4539" xml_f="4692" txt_i="1137" txt_f="1290">; the score of group L was significantly lower than that of group H. Other vital signs and complications showed a minimal differences between two groups.</offsets></p></sec><sec><title><offsets xml_i="4714" xml_f="4725" txt_i="1292" txt_f="1303">Conclusions</offsets></title><p><offsets xml_i="4736" xml_f="4848" txt_i="1304" txt_f="1416">Higher loading dose (1.0 µg/kg) of dexmedetomidine can lead to faster sedation without any severe complications.</offsets></p></sec></abstract><kwd-group><kwd>Conscious sedation</kwd><kwd>Dexmedetomidine</kwd></kwd-group><funding-group><award-group><funding-source country="KR">Chungbuk National University</funding-source></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="5137" xml_f="5149" txt_i="1425" txt_f="1437">Introduction</offsets></title><p><offsets xml_i="5160" xml_f="5215" txt_i="1438" txt_f="1493">Dexmedetomidine is a highly selective alpha 2 agonist [</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="5246" xml_f="5247" txt_i="1493" txt_f="1494">1</offsets></xref><offsets xml_i="5254" xml_f="5384" txt_i="1494" txt_f="1624">]. This drug activates alpha 2 receptors in the locus ceruleus of the brain, resulting in very effective sedation of the patient [</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="5415" xml_f="5416" txt_i="1624" txt_f="1625">2</offsets></xref><offsets xml_i="5423" xml_f="5558" txt_i="1625" txt_f="1760">]. Unlike many other sedative drugs that cause respiratory depression during sedation, dexmedetomidine is free from such side effects [</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="5589" xml_f="5590" txt_i="1760" txt_f="1761">3</offsets></xref><offsets xml_i="5597" xml_f="5598" txt_i="1761" txt_f="1762">,</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="5629" xml_f="5630" txt_i="1762" txt_f="1763">4</offsets></xref><offsets xml_i="5637" xml_f="5638" txt_i="1763" txt_f="1764">,</offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="5669" xml_f="5670" txt_i="1764" txt_f="1765">5</offsets></xref><offsets xml_i="5677" xml_f="5678" txt_i="1765" txt_f="1766">,</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="5709" xml_f="5710" txt_i="1766" txt_f="1767">6</offsets></xref><offsets xml_i="5717" xml_f="5930" txt_i="1767" txt_f="1980">]. This advantage contributes to the variable use of dexmedetomidine, not only in the critical care unit as originally intended, but also in sedation and anesthesia in both preoperative and postoperative periods [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="5961" xml_f="5962" txt_i="1980" txt_f="1981">7</offsets></xref><offsets xml_i="5969" xml_f="5971" txt_i="1981" txt_f="1983">].</offsets></p><p><offsets xml_i="5978" xml_f="6310" txt_i="1984" txt_f="2316">However, this alpha 2 agonist has its own side effects. Activation of the alpha 2 receptors in peripheral vessels causes unexpected hypertension and bradycardia during the first few minutes of infusion, and the converse may occur after this period: rebound of the autonomic nervous system can result in hypotension and tachycardia [</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="6341" xml_f="6342" txt_i="2316" txt_f="2317">8</offsets></xref><offsets xml_i="6349" xml_f="6350" txt_i="2317" txt_f="2318">,</offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="6381" xml_f="6382" txt_i="2318" txt_f="2319">9</offsets></xref><offsets xml_i="6389" xml_f="6391" txt_i="2319" txt_f="2321">].</offsets></p><p><offsets xml_i="6398" xml_f="6588" txt_i="2322" txt_f="2512">The dosing of dexmedetomidine varies based on its purpose, although clinical use usually suggests a loading dose of 0.5-1.0 µg/kg for 10 minutes and a maintenance dose of 0.2-0.7 µg/kg/min [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="6619" xml_f="6620" txt_i="2512" txt_f="2513">7</offsets></xref><offsets xml_i="6627" xml_f="6757" txt_i="2513" txt_f="2643">]. We designed this study to investigate the clinical effects and complications at two different loading doses, 0.5 and 1.0 µg/kg.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="6808" xml_f="6829" txt_i="2645" txt_f="2666">Materials and Methods</offsets></title><p><offsets xml_i="6840" xml_f="7380" txt_i="2667" txt_f="3207">Forty six patients, of American Society of Anesthesiologists physical status I and II, who required elective and emergency operation under spinal anesthesia were enrolled in this prospective, randomized, double-blind study. The exclusion criteria were underlying neurologic and cardiovascular disease, renal failure, liver failure and contraindication cases of spinal anesthesia such as bleeding tendency, patient refusal. The study was approved by the Institutional Review Board and written informed consent was obtained from each patient.</offsets></p><p><offsets xml_i="7387" xml_f="7877" txt_i="3208" txt_f="3698">All patients fasted for 8 hours before the operation, and no premedications were administered. In the operating room, 5 L/min of oxygen was provided to patients via an oxygen mask and an intravenous line was placed in each patient's forearm. Before spinal anesthesia, Ringer's lactate solution 10 ml/kg was administered intravenously as pre-hydration. The patients were placed in the lateral decubitus position and spinal punctures were performed using a 25-gauge Quincke spinal needle at L</offsets><sub><offsets xml_i="7882" xml_f="7885" txt_i="3698" txt_f="3701">3-4</offsets></sub><offsets xml_i="7891" xml_f="7896" txt_i="3701" txt_f="3706"> or L</offsets><sub><offsets xml_i="7901" xml_f="7904" txt_i="3706" txt_f="3709">4-5</offsets></sub><offsets xml_i="7910" xml_f="8361" txt_i="3709" txt_f="4160">. Hyperbaric 0.5% bupivacaine 12 mg was administered intrathecally and lied down immediately. In all patients, spinal anesthesia was successfully conducted, and sensory block level was evaluated in pin prick test by using 25 G needle. After wiping the patient's forehead with alcohol gauze, a BIS monitor (Model A 3000, Aspect Medical systems, Natick, MA, USA) was placed and the initial BIS value was recorded. Heart rate (HR), oxygen saturation (SpO</offsets><sub><offsets xml_i="8366" xml_f="8367" txt_i="4160" txt_f="4161">2</offsets></sub><offsets xml_i="8373" xml_f="8419" txt_i="4161" txt_f="4207">), non-invasive blood pressure, Ramsay score (</offsets><xref ref-type="table" rid="T1"><offsets xml_i="8451" xml_f="8458" txt_i="4207" txt_f="4214">Table 1</offsets></xref><offsets xml_i="8465" xml_f="8578" txt_i="4214" txt_f="4327">) and BIS were closely monitored in all patients, before administration of the loading dose of dexmedetomidine (T</offsets><sub><offsets xml_i="8583" xml_f="8584" txt_i="4327" txt_f="4328">0</offsets></sub><offsets xml_i="8590" xml_f="8614" txt_i="4328" txt_f="4352">), just after loading (T</offsets><sub><offsets xml_i="8619" xml_f="8620" txt_i="4352" txt_f="4353">L</offsets></sub><offsets xml_i="8626" xml_f="8666" txt_i="4353" txt_f="4393">), and at 10 min intervals thereafter (T</offsets><sub><offsets xml_i="8671" xml_f="8673" txt_i="4393" txt_f="4395">10</offsets></sub><offsets xml_i="8679" xml_f="8682" txt_i="4395" txt_f="4398">, T</offsets><sub><offsets xml_i="8687" xml_f="8689" txt_i="4398" txt_f="4400">20</offsets></sub><offsets xml_i="8695" xml_f="8698" txt_i="4400" txt_f="4403">, T</offsets><sub><offsets xml_i="8703" xml_f="8705" txt_i="4403" txt_f="4405">30</offsets></sub><offsets xml_i="8711" xml_f="8714" txt_i="4405" txt_f="4408">) [</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8746" xml_f="8748" txt_i="4408" txt_f="4410">10</offsets></xref><offsets xml_i="8755" xml_f="8757" txt_i="4410" txt_f="4412">].</offsets></p><p><offsets xml_i="8764" xml_f="9082" txt_i="4413" txt_f="4731">Loading was started immediately after 20 minutes in a manner corresponding to the loading dose of each group: group H with 1.0 µg/kg and group L with 0.5 µg/kg. After 10 minutes of loading, dosing was changed to a maintenance dose, 0.5 µg/kg/min. All data were recorded every 10 minutes until the end of the operation.</offsets></p><p><offsets xml_i="9089" xml_f="9266" txt_i="4732" txt_f="4909">After the operation, infusion of dexmedetomidine was stopped. The lowest BIS score during the operation and the time to reach BIS 80 after termination of infusion were recorded.</offsets></p><p><offsets xml_i="9273" xml_f="9640" txt_i="4910" txt_f="5265">Aside from the primary data, all complications were recorded when they occurred. Complications were defined as hypertension (systolic blood pressure or mean arterial pressure &gt; 20% of baseline), hypotension (systolic blood pressure &lt; 80 mmHg), bradycardia (heart rate &lt; 50 beats/min), tachycardia (heart rate &gt; 100 beats/min for 5 minutes), hypoxemia (SpO</offsets><sub><offsets xml_i="9645" xml_f="9646" txt_i="5265" txt_f="5266">2</offsets></sub><offsets xml_i="9652" xml_f="9779" txt_i="5266" txt_f="5390">&lt; 95%) and oral dryness. Ephedrine and atropine used for the rescue of such complications were also recorded after each use.</offsets></p><p><offsets xml_i="9786" xml_f="9980" txt_i="5391" txt_f="5585">All measures were displayed as mean ± standard deviation (SD). When BIS had a difference of 10 or more, the α value was set at 0.05, the β value was set at 0.2 and the sample size was set at 23.</offsets></p><p><offsets xml_i="9987" xml_f="10309" txt_i="5586" txt_f="5908">Statistical analysis was performed using R 3.0.0. for Windows. Enumeration data such as sex, incidence of side effects and use of drugs were compared with Chi-square analysis. Nonenumeration data such as BIS, SBP, and HR were compared by Student's t-test. P values less than 0.05 were considered statistically significant.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="10350" xml_f="10357" txt_i="5910" txt_f="5917">Results</offsets></title><p><offsets xml_i="10368" xml_f="10581" txt_i="5918" txt_f="6131">Forty-six patients were enrolled in this study. No patients were excluded and patient characteristics such as sex, age, height, weight and sensory block level showed no significant differences between two groups (</offsets><xref ref-type="table" rid="T2"><offsets xml_i="10613" xml_f="10620" txt_i="6131" txt_f="6138">Table 2</offsets></xref><offsets xml_i="10627" xml_f="10629" txt_i="6138" txt_f="6140">).</offsets></p><p><offsets xml_i="10636" xml_f="10689" txt_i="6141" txt_f="6194">In group H, BIS value decreased significantly after T</offsets><sub><offsets xml_i="10694" xml_f="10695" txt_i="6194" txt_f="6195">L</offsets></sub><offsets xml_i="10701" xml_f="10729" txt_i="6195" txt_f="6223"> compared to the baseline (T</offsets><sub><offsets xml_i="10734" xml_f="10735" txt_i="6223" txt_f="6224">0</offsets></sub><offsets xml_i="10741" xml_f="10768" txt_i="6224" txt_f="6251">), while in group L after T</offsets><sub><offsets xml_i="10773" xml_f="10775" txt_i="6251" txt_f="6253">10</offsets></sub><offsets xml_i="10781" xml_f="10783" txt_i="6253" txt_f="6255"> (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="10813" xml_f="10819" txt_i="6255" txt_f="6261">Fig. 1</offsets></xref><offsets xml_i="10826" xml_f="10902" txt_i="6261" txt_f="6337">). Between two groups, BIS values showed a significant differences only at T</offsets><sub><offsets xml_i="10907" xml_f="10909" txt_i="6337" txt_f="6339">10</offsets></sub><offsets xml_i="10915" xml_f="11107" txt_i="6339" txt_f="6531">, BIS of group H was lower than that of group L. However, the other BIS parameters (the lowest BIS value and time to reach BIS 80) did not show any significant differences between two groups (</offsets><xref ref-type="table" rid="T3"><offsets xml_i="11139" xml_f="11146" txt_i="6531" txt_f="6538">Table 3</offsets></xref><offsets xml_i="11153" xml_f="11155" txt_i="6538" txt_f="6540">).</offsets></p><p><offsets xml_i="11162" xml_f="11233" txt_i="6541" txt_f="6612">Throughout this study, heart rate decreased significantly rather than T</offsets><sub><offsets xml_i="11238" xml_f="11239" txt_i="6612" txt_f="6613">0</offsets></sub><offsets xml_i="11245" xml_f="11335" txt_i="6613" txt_f="6703"> value in the both groups. But, there were no significant differences between two groups (</offsets><xref ref-type="fig" rid="F2"><offsets xml_i="11365" xml_f="11371" txt_i="6703" txt_f="6709">Fig. 2</offsets></xref><offsets xml_i="11378" xml_f="11380" txt_i="6709" txt_f="6711">).</offsets></p><p><offsets xml_i="11387" xml_f="11463" txt_i="6712" txt_f="6788">Systolic blood pressure did not show any significant differences except at T</offsets><sub><offsets xml_i="11468" xml_f="11470" txt_i="6788" txt_f="6790">30</offsets></sub><offsets xml_i="11476" xml_f="11536" txt_i="6790" txt_f="6850"> in group L, where SBP was significantly lower rather than T</offsets><sub><offsets xml_i="11541" xml_f="11542" txt_i="6850" txt_f="6851">0</offsets></sub><offsets xml_i="11548" xml_f="11550" txt_i="6851" txt_f="6853"> (</offsets><xref ref-type="fig" rid="F3"><offsets xml_i="11580" xml_f="11586" txt_i="6853" txt_f="6859">Fig. 3</offsets></xref><offsets xml_i="11593" xml_f="11682" txt_i="6859" txt_f="6948">). Between two groups, SBP value in both groups showed a significant difference only at T</offsets><sub><offsets xml_i="11687" xml_f="11688" txt_i="6948" txt_f="6949">L</offsets></sub><offsets xml_i="11694" xml_f="11749" txt_i="6949" txt_f="7004">, SBP value of group L was lower than that of group H (</offsets><xref ref-type="fig" rid="F3"><offsets xml_i="11779" xml_f="11785" txt_i="7004" txt_f="7010">Fig. 3</offsets></xref><offsets xml_i="11792" xml_f="11794" txt_i="7010" txt_f="7012">).</offsets></p><p><offsets xml_i="11801" xml_f="11932" txt_i="7013" txt_f="7144">There were no significant differences between two groups in the incidence of bradycardia, hypoxemia, hypotension and hypertension (</offsets><xref ref-type="table" rid="T3"><offsets xml_i="11964" xml_f="11971" txt_i="7144" txt_f="7151">Table 3</offsets></xref><offsets xml_i="11978" xml_f="11980" txt_i="7151" txt_f="7153">).</offsets></p><p><offsets xml_i="11987" xml_f="12124" txt_i="7154" txt_f="7291">Incidence of oral dryness, tachycardia, excessive bradycardia and use of atropine and ephedrine did not show any significant differences.</offsets></p><p><offsets xml_i="12131" xml_f="12196" txt_i="7292" txt_f="7357">Ramsay score did not show any significant differences except at T</offsets><sub><offsets xml_i="12201" xml_f="12202" txt_i="7357" txt_f="7358">L</offsets></sub><offsets xml_i="12208" xml_f="12286" txt_i="7358" txt_f="7436"> when the score of group L was significantly lower than the score of group H (</offsets><xref ref-type="fig" rid="F4"><offsets xml_i="12316" xml_f="12322" txt_i="7436" txt_f="7442">Fig. 4</offsets></xref><offsets xml_i="12329" xml_f="12331" txt_i="7442" txt_f="7444">).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="12375" xml_f="12385" txt_i="7446" txt_f="7456">Discussion</offsets></title><p><offsets xml_i="12396" xml_f="12494" txt_i="7457" txt_f="7555">Dexmedetomidine is a highly selective alpha 2-agonist that is used in the operating room and ICU [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="12525" xml_f="12526" txt_i="7555" txt_f="7556">7</offsets></xref><offsets xml_i="12533" xml_f="12685" txt_i="7556" txt_f="7708">]. Its unique characteristics of powerful sedation without respiratory depression make dexmedetomidine one of the most useful drugs in sedative fields [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="12716" xml_f="12717" txt_i="7708" txt_f="7709">7</offsets></xref><offsets xml_i="12724" xml_f="12725" txt_i="7709" txt_f="7710">,</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="12757" xml_f="12759" txt_i="7710" txt_f="7712">11</offsets></xref><offsets xml_i="12766" xml_f="12768" txt_i="7712" txt_f="7714">].</offsets></p><p><offsets xml_i="12775" xml_f="13045" txt_i="7715" txt_f="7985">In our study, both groups showed significantly lower BIS values compared to baseline after loading, although the breakpoint was different. In group L, the significant difference revealed itself 10 minutes after loading, while in group H it occurred right after loading (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="13075" xml_f="13081" txt_i="7985" txt_f="7991">Fig. 1</offsets></xref><offsets xml_i="13088" xml_f="13177" txt_i="7991" txt_f="8080">). BIS values between the two groups did not show any significant differences except at T</offsets><sub><offsets xml_i="13182" xml_f="13184" txt_i="8080" txt_f="8082">10</offsets></sub><offsets xml_i="13190" xml_f="13397" txt_i="8082" txt_f="8289">, where the BIS value of group H was lower than that of group L. Previous investigations commented that an increase in loading dose and plasma concentration of dexmedetomidine resulted in improved sedation [</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="13429" xml_f="13431" txt_i="8289" txt_f="8291">12</offsets></xref><offsets xml_i="13438" xml_f="13612" txt_i="8291" txt_f="8465">]. In addition to affirmative results in the past, it has been suggested that dexmedetomidine has a dose-dependent sedation effect, which may be altered by the loading dose [</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="13644" xml_f="13646" txt_i="8465" txt_f="8467">13</offsets></xref><offsets xml_i="13653" xml_f="14012" txt_i="8467" txt_f="8826">]. These results indicate that a higher loading dose of dexmedetomidine may lead to more rapid sedation. As faster sedation is one of the major goals in the use of dexmedetomidine, a loading dose of 1.0 µg/kg may be far superior to 0.5 µg/kg in terms of sedation. A recent trial indicated that a BIS value of 65 to 85 may be an optimal standard for sedation [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="14044" xml_f="14046" txt_i="8826" txt_f="8828">14</offsets></xref><offsets xml_i="14053" xml_f="14139" txt_i="8828" txt_f="8914">]. According to our data, group H showed faster entrance to BIS below 85 than group L.</offsets></p><p><offsets xml_i="14146" xml_f="14191" txt_i="8915" txt_f="8960">Ramsay score differed significantly only at T</offsets><sub><offsets xml_i="14196" xml_f="14197" txt_i="8960" txt_f="8961">L</offsets></sub><offsets xml_i="14203" xml_f="14334" txt_i="8961" txt_f="9092">, where the value of group L was lower than that of group H. Group H showed successful entrance to the Ramsay score above 3 after T</offsets><sub><offsets xml_i="14339" xml_f="14340" txt_i="9092" txt_f="9093">L</offsets></sub><offsets xml_i="14346" xml_f="14369" txt_i="9093" txt_f="9116">, while group L after T</offsets><sub><offsets xml_i="14374" xml_f="14376" txt_i="9116" txt_f="9118">10</offsets></sub><offsets xml_i="14382" xml_f="14459" txt_i="9118" txt_f="9195">. We have found reports that Ramsay score of 3 to 4 is optimal for sedation [</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="14491" xml_f="14493" txt_i="9195" txt_f="9197">15</offsets></xref><offsets xml_i="14500" xml_f="14600" txt_i="9197" txt_f="9297">]. Also, this score roughly corresponds to BIS 69 to 81, which is acceptable to our result as well [</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="14632" xml_f="14634" txt_i="9297" txt_f="9299">16</offsets></xref><offsets xml_i="14641" xml_f="14736" txt_i="9299" txt_f="9394">]. The superiority of the higher loading dose in faster sedation is well reflected in our data.</offsets></p><p><offsets xml_i="14743" xml_f="15014" txt_i="9395" txt_f="9666">HR values were significantly lower than the baseline value at all points, while no significant differences were shown between two groups. These data are consistent with previous investigations that dexmedetomidine has a great relation to the complication of bradycardia [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="15045" xml_f="15046" txt_i="9666" txt_f="9667">7</offsets></xref><offsets xml_i="15053" xml_f="15055" txt_i="9667" txt_f="9669">].</offsets></p><p><offsets xml_i="15062" xml_f="15123" txt_i="9670" txt_f="9731">The SBP of the two groups showed significant differences at T</offsets><sub><offsets xml_i="15128" xml_f="15129" txt_i="9731" txt_f="9732">L</offsets></sub><offsets xml_i="15135" xml_f="15359" txt_i="9732" txt_f="9956">, when the SBP of group H was higher than that of group L. This corresponds to results of past research that indicated that a greater loading dose of dexmedetomidine may result in faster incidence of transient hypertension [</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="15391" xml_f="15393" txt_i="9956" txt_f="9958">17</offsets></xref><offsets xml_i="15400" xml_f="15401" txt_i="9958" txt_f="9959">,</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="15433" xml_f="15435" txt_i="9959" txt_f="9961">18</offsets></xref><offsets xml_i="15442" xml_f="15444" txt_i="9961" txt_f="9963">].</offsets></p><p><offsets xml_i="15451" xml_f="15696" txt_i="9964" txt_f="10209">In total, use of a higher loading dose of dexmedetomidine results in faster effects, whether sedation or cardiovascular features. These data suggest that the cardiovascular effects of dexmedetomidine are related to its concentration and dosing [</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="15728" xml_f="15730" txt_i="10209" txt_f="10211">19</offsets></xref><offsets xml_i="15737" xml_f="15739" txt_i="10211" txt_f="10213">].</offsets></p><p><offsets xml_i="15746" xml_f="16005" txt_i="10214" txt_f="10473">The subjectivity of the Ramsay score calls for attention however. Values such as SBP, HR, and BIS are perfectly numerated and can be defined objectively by anyone. However, the Ramsay score requires a small 'interview' and may differ by patient or questioner.</offsets></p><p><offsets xml_i="16012" xml_f="16257" txt_i="10474" txt_f="10719">In conclusion, the 1 µg/kg loading dose of dexmedetomidine can lead to faster sedation without any severe complication. So, for rapid sedation after spinal anesthesia, a higher loading dose such as 1 µg/kg may be an optimal choice for this drug.</offsets></p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the research grant of Chungbuk National University in 2013.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>In</surname><given-names>JH</given-names></name><name><surname>Jung</surname><given-names>HS</given-names></name><name><surname>Jeon</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>Comparison of an intraoperative infusion of dexmedetomidine or fentanyl for the perioperative hemodynamics, achieving hypnosis and sedation and the postoperative pain control</article-title><source>Anesth Pain Med</source><year>2011</year><volume>6</volume><fpage>125</fpage><lpage>130</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>RM</given-names></name><name><surname>Hell</surname><given-names>J</given-names></name><name><surname>Grounds</surname><given-names>RM</given-names></name></person-group><article-title>Respiratory effects of dexmedetomidine in the surgical patients requiring intensive care</article-title><source>Crit Care</source><year>2000</year><volume>4</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">11056756</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>AT</given-names></name><name><surname>Dasta</surname><given-names>JF</given-names></name></person-group><article-title>Dexmedetomidine: an updated review</article-title><source>Ann Pharmacother</source><year>2007</year><volume>41</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">17299013</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>YW</given-names></name><name><surname>Cortinez</surname><given-names>LI</given-names></name><name><surname>Robertson</surname><given-names>KM</given-names></name><name><surname>Keifer</surname><given-names>JC</given-names></name><name><surname>Sum-Ping</surname><given-names>ST</given-names></name><name><surname>Moretti</surname><given-names>EW</given-names></name><etal></etal></person-group><article-title>Dexmedetomidine pharmacodynamics: part 1: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers</article-title><source>Anesthesiology</source><year>2004</year><volume>101</volume><fpage>1066</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">15505441</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhana</surname><given-names>N</given-names></name><name><surname>Goa</surname><given-names>KL</given-names></name><name><surname>McClellan</surname><given-names>KJ</given-names></name></person-group><article-title>Dexmedetomidine</article-title><source>Drugs</source><year>2000</year><volume>59</volume><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">10730549</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name></person-group><article-title>Clinical use of dexmedetomidine in monitored anesthesia care</article-title><source>Korean J Anesthesiol</source><year>2011</year><volume>61</volume><fpage>451</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">22220219</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Cang</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>Z</given-names></name></person-group><article-title>Effects of different loading doses of dexmedetomidine on bispectral index under stepwise propofol target-controlled infusion</article-title><source>Pharmacology</source><year>2013</year><volume>91</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23095710</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herr</surname><given-names>DL</given-names></name><name><surname>Sum-Ping</surname><given-names>ST</given-names></name><name><surname>England</surname><given-names>M</given-names></name></person-group><article-title>ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens</article-title><source>J Cardiothorac Vasc Anesth</source><year>2003</year><volume>17</volume><fpage>576</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">14579210</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>SM</given-names></name><name><surname>Keating</surname><given-names>GM</given-names></name></person-group><article-title>Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation</article-title><source>Drugs</source><year>2011</year><volume>71</volume><fpage>1481</fpage><lpage>1501</lpage><pub-id pub-id-type="pmid">21812509</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsay</surname><given-names>MA</given-names></name><name><surname>Savege</surname><given-names>TM</given-names></name><name><surname>Simpson</surname><given-names>BR</given-names></name><name><surname>Goodwin</surname><given-names>R</given-names></name></person-group><article-title>Controlled sedation with alphaxalone-alphadolone</article-title><source>Br Med J</source><year>1974</year><volume>2</volume><fpage>656</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">4835444</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kose</surname><given-names>EA</given-names></name><name><surname>Honca</surname><given-names>M</given-names></name><name><surname>Yilmaz</surname><given-names>E</given-names></name><name><surname>Batislam</surname><given-names>E</given-names></name><name><surname>Apan</surname><given-names>A</given-names></name></person-group><article-title>Comparison of effects of dexmedetomidine-ketamine and dexmedetomidine-midazolam combinations in transurethral procedures</article-title><source>Urology</source><year>2012</year><volume>79</volume><fpage>1214</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">22656405</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>TJ</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Colinco</surname><given-names>MD</given-names></name></person-group><article-title>The effects of increasing plasma concentration of dexmedetomidine in humans</article-title><source>Anesthesiology</source><year>2000</year><volume>93</volume><fpage>382</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">10910487</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Stalker</surname><given-names>D</given-names></name><name><surname>Wisemandle</surname><given-names>W</given-names></name><name><surname>Shin</surname><given-names>SG</given-names></name><etal></etal></person-group><article-title>Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects</article-title><source>J Clin Pharm Ther</source><year>2012</year><volume>37</volume><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">22650799</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>GH</given-names></name></person-group><chapter-title>Monitoring and Anesthesia Record</chapter-title><collab collab-type="editors">Edited by the Korean Society of Anesthesiologist</collab><source>Anesthesiology and Pain Medicine</source><edition>2nd ed</edition><publisher-loc>Seoul</publisher-loc><publisher-name>Ryo Moon Gak</publisher-name><year>2010</year><fpage>142</fpage><lpage>143</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strøm</surname><given-names>T</given-names></name></person-group><article-title>Sedation in the ICU</article-title><source>Dan Med J</source><year>2012</year><volume>59</volume><fpage>B4458</fpage><pub-id pub-id-type="pmid">22549494</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondello</surname><given-names>E</given-names></name><name><surname>Siliotti</surname><given-names>R</given-names></name><name><surname>Noto</surname><given-names>G</given-names></name><name><surname>Cuzzocrea</surname><given-names>E</given-names></name><name><surname>Scollo</surname><given-names>G</given-names></name><name><surname>Trimarchi</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Bispectral index in ICU: correlation with Ramsay Score on assessment of sedation level</article-title><source>J Clin Monit Comput</source><year>2002</year><volume>17</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">12546259</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maze</surname><given-names>M</given-names></name><name><surname>Scarfini</surname><given-names>C</given-names></name><name><surname>Cavaliere</surname><given-names>F</given-names></name></person-group><article-title>New agents for sedation in the intensive care unit</article-title><source>Crit Care Clin</source><year>2001</year><volume>17</volume><fpage>881</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">11762266</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloor</surname><given-names>BC</given-names></name><name><surname>Ward</surname><given-names>DS</given-names></name><name><surname>Belleville</surname><given-names>JP</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>1134</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">1361311</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>ZP</given-names></name><name><surname>Ferguson</surname><given-names>CN</given-names></name><name><surname>Jones</surname><given-names>RM</given-names></name></person-group><article-title>Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role</article-title><source>Anaesthesia</source><year>1999</year><volume>54</volume><fpage>146</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">10215710</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Bispectral index during sedation. <sup>*</sup>P &lt; 0.05 compared to T<sub>0</sub>, <sup>†</sup>P &lt; 0.05 between two groups, Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg, T<sub>0</sub>: start of anesthesia, T<sub>L</sub>: after loading, T<sub>10</sub>: 10 minutes after T<sub>L</sub>, T<sub>20</sub>: 20 minutes after T<sub>L</sub>, T<sub>30</sub>: 30 minutes after T<sub>L</sub>.</p></caption><graphic xlink:href="kjae-67-8-g001"></graphic></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Heart rate during sedation. <sup>*</sup>P &lt; 0.05 compared to T<sub>0</sub>. Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg, T<sub>0</sub>: start of anesthesia, T<sub>L</sub>: after loading, T<sub>10</sub>: 10 minutes after T<sub>L</sub>, T<sub>20</sub>: 20 minutes after T<sub>L</sub>, T<sub>30</sub>: 30 minutes after T<sub>L</sub>.</p></caption><graphic xlink:href="kjae-67-8-g002"></graphic></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Systolic blood pressure during sedation.<sup>*</sup>P &lt; 0.05 compare to T<sub>0</sub>, <sup>†</sup>P &lt; 0.05 between two groups, Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg, T<sub>0</sub>: start of anesthesia, T<sub>L</sub>: after loading, T<sub>10</sub>: 10 minutes after T<sub>L</sub>, T<sub>20</sub>: 20 minutes after T<sub>L</sub>, T<sub>30</sub>: 30 minutes after T<sub>L</sub>.</p></caption><graphic xlink:href="kjae-67-8-g003"></graphic></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Ramsay-score during sedation. <sup>*</sup>P &lt; 0.05 compare to T<sub>0</sub>, <sup>†</sup>P &lt; 0.05 between two groups, Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg, T0: start of anesthesia, T<sub>L</sub>: after loading, T<sub>10</sub>: 10 minutes after T<sub>L</sub>, T<sub>20</sub>: 20 minutes after T<sub>L</sub>, T<sub>30</sub>: 30 minutes after T<sub>L</sub>.</p></caption><graphic xlink:href="kjae-67-8-g004"></graphic></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Ramsay Sedation Scale</p></caption><graphic xlink:href="kjae-67-8-i001"></graphic></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Patient Characteristics</p></caption><graphic xlink:href="kjae-67-8-i002"></graphic><table-wrap-foot><fn><p>Values are mean ± SD or number of patients. There are no significant differences between two groups. Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Complications, Drug Use, Minimal BIS and Time to Reach BIS 80</p></caption><graphic xlink:href="kjae-67-8-i003"></graphic><table-wrap-foot><fn><p>Values are mean ± SD or number of patients. There are no significant differences between two groups. Group L: loading dose 0.5 µg/kg, Group H: loading dose 1.0 µg/kg. BISmin: Lowest value of BIS during the study.</p></fn></table-wrap-foot></table-wrap></floats-group></article>